Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911645 · ClinicalTrials.gov registry record · NA
Diagnostic Reasoning With Customized GPT-4 Model
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT06911645: Completed NA study, sponsored by Stanford University.
NCT06911645 is a NA study that has completed, run by Stanford University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06911645, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will assess the impact of immediate access to a customized version of GPT-4, a large language model, on performance in case-based diagnostic reasoning tasks. Specifically, it will compare this approach to a two-step process where participants first use traditional diagnostic decision support tools to support their diagnostic reasoning before gaining access to the customized GPT-4 model.
Interventions
- OTHER Immediate access to customized version of GPT-4
- OTHER Access to customized version of GPT-4 following use of conventional resources
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2025-01-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06911645
The ClinicalTrials.gov registry entry for NCT06911645 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Immediate access to customized version of GPT-4 is the first listed.
NCT06911645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06911645 about?
NCT06911645 is a clinical study titled "Diagnostic Reasoning With Customized GPT-4 Model". This study will assess the impact of immediate access to a customized version of GPT-4, a large language model, on performance in case-based diagnostic reasoning tasks. Specifically, it will compare this approach to a two-step process where participants first use traditional diagnostic decision supp...
What is the current status of trial NCT06911645?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-12-16. Estimated completion is 2025-01-24.
What interventions are being tested in trial NCT06911645?
The interventions under investigation include: Immediate access to customized version of GPT-4 (OTHER), Access to customized version of GPT-4 following use of conventional resources (OTHER).
Who is sponsoring clinical trial NCT06911645?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.